ARTICLE | Emerging Company Profile
Sorting out antibody competition
September 23, 1996 7:00 AM UTC
Coulter & Idec
Coulter Pharmaceutical Inc. isn't alone in developing an anti-CD20 antibody for lymphoma. Idec Pharmaceuticals Corp. (IDPH) is developing its own antibody in several configurations: as a "cold" antibody treatment; in combination with CHOP chemotherapy, and as a "hot" antibody conjugated with the radioisotope yttrium...